Article citationsMore >>

Cai K.Q., Caslini C., Capo-chichi C.D., Slater C., Smith E.R., Wu H., Klein-Szanto A.J., Godwin A.K., Xu X.X. Loss of GATA4 and GATA6 expression specifies ovarian cancer histological subtypes and precedes neoplastic transformation of ovarian surface epithelia. PloS one, 4(7):6454, July 2009.

has been cited by the following article:

Article

Deficiency of GATA6 as a Molecular Tool to Assess the Risk for Cervical Cancer

1Faculty of Sciences and technology (FAST) / Laboratory of Biochemistry and molecular biology (LBBM), Institute of Biomedical Sciences and Applications (ISBA) / University Abomey-Calavi (UAC), Benin

2Gynecology/obstetric service and CIPEC, CHDU Borgou, Parakou, Bénin

3Gynecology/obstetric and oncology services, CNHU, UAC, Cotonou, BENIN

4Gynecology/obstetric service, Hospital Mènontin, Cotonou, Benin

5Sylvester Cancer Center/Miller Medical School of Medicine, University of Miami, USA


American Journal of Biomedical Research. 2014, Vol. 2 No. 1, 1-6
DOI: 10.12691/ajbr-2-1-1
Copyright © 2014 Science and Education Publishing

Cite this paper:
Capo-chichi D. Callinice, Alladagbin D. Jeanne, Brun Luc, Aguida Blanche, Agossou Komlan Vidéhouénou, Anagbla Toussain, Salmane Amidou, Xu Xiang-Xi, Sanni Ambaliou. Deficiency of GATA6 as a Molecular Tool to Assess the Risk for Cervical Cancer. American Journal of Biomedical Research. 2014; 2(1):1-6. doi: 10.12691/ajbr-2-1-1.

Correspondence to: Capo-chichi  D. Callinice, Faculty of Sciences and technology (FAST) / Laboratory of Biochemistry and molecular biology (LBBM), Institute of Biomedical Sciences and Applications (ISBA) / University Abomey-Calavi (UAC), Benin. Email: callinice.capochichi@gmail.com

Abstract

Introduction: GATA6 is a transcription factor which has role in the induction of cell differentiation genes and the maintenance of the differentiated state of epithelial cells. GATA6 expression is lost in neoplastic ovarian epithelia cells and in ovarian carcinoma leading to abnormal nuclear morphology characteristic of most cancer cells. We investigated the profile of GATA6 in cells collected from cervical-uterine smears (CUS) of women in the gynecologic service of three hospitals in Benin. Objective: To utilize GATA6 as molecular marker for the screening of women at risk of developing cervical carcinomas. Methods: CUS were collected from forty (40) women coming for regular checkup (a) at the National University Hospital (CNHU) in Cotonou and (b) from the local hospital of Mènontin (HZ) in Cotonou (south of Benin); (c) forty other (40) CUS were collected from women coming for treatment against HIV1 in the service of gynecology of the Departmental University Hospital (CHDU) of Borgouin Parakou (north of Benin). GATA6 was analyzed in cells isolated from 80 CUS totally by the immunoblotting techniques. Results: In women from Cotonou, GATA6waspresent in 17/40 (42%) CUS, lightly expressed in 10/40 (25%) CUS and totally absent in /40 (32.5%) CUS. In the HIV1 infected women under treatment in Parakou, GATA6 was present in 8/40 (20%) CUS, lightly expressed in 13/40 (32.5%) and totally lost in 19/40 (47.5%) CUS. Conclusion: Our study showed that the loss of GATA6 in CUS was significantly higher in the population of women infected with HIV1 than in women from regular population in Cotonou. Thus the deficiency in GATA6 expression maybe utilizedas diagnostic tools to identify women at risk for developing cervical carcinomas regardless the infectious status before the onset of neoplasia.

Keywords